secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001213900-23-099880
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital postpones extraordinary general meeting to Jan 9, extends redemption deadline
--------------------------------------------------------------------------------

- Extraordinary general meeting moved from Jan 4 to Jan 9, 2024 at 9:00 AM ET.
- Redemption request deadline extended to Jan 5, 2024 at 5:00 PM ET.
- Meeting location unchanged; virtual attendance now also available via live webcast.
- No change to record date (Dec 14, 2023) or proposals to be voted on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023099880/0001213900-23-099880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390023099880/ea190880-8k425_denalicap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-099880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer